Skip to content

Cortical Excitability Using Robotised and Neuronavigated Transcranial Magnetic Stimulation

Development of New Cortical Excitability Methodologies Using Robotised and Neuronavigated Transcranial Magnetic Stimulation.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02168413
Acronym
ROBEXCI
Enrollment
144
Registered
2014-06-20
Start date
2014-05-14
Completion date
2021-05-12
Last updated
2021-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cortical Excitability, Robotized TMS

Keywords

cortical excitability, robotized TMS, EEG, EMG

Brief summary

This study has two main goals : * to develop the cortcial excitbality (CE) measurement methodology using coupling between transcranial magnetic stimulation (TMS) and physiological recordings such as electroencephalography (EEG) and electromyography (EMG), * to automatize these measurements using robotized TMS. Assessing CE is a preliminary and crucial step in any TMS protocol, in either fundamental or clinical research. It is an important indicator which determine the stimulation power applied on the cortical target during the TMS experiment, or during the rTMS cure (patients). CE is in general measured on the motor cortex using EMG activity as the main indicator of the system's response, whatever the real cortical target is located. The present study thus propose to generalize this measurement on other cortical areas in link with the actual targets, and using other external recordings such as EEG. Moreover, as neuronavigation systems significantly improved TMS precision in the past years, CE measurements could significantly gain to become fully automatized using robotized TMS.

Detailed description

Eligibility Criteria : CRITERIA OF INCLUSION * Major Topic (18 to 75) * Signed informed consent, * A medical examination must be done before participation in research, * Membership or beneficiary of a social security scheme, CRITERIA OF NON-INCLUSION * Topic of under 18 and over 75 years. * Against-indications (CI) to the practice of MRI pacemaker or implantable defibrillator or pacemaker neurosensory (risk of temporary or permanent damage to the device or heating metal parts). Cochlear implants (risk of demagnetization, electrode temperature rise and artifacts). Ocular or cerebral ferromagnetic foreign body close to the nerve structures (risk of displacement and complications such as eye or brain damage). Metal prostheses (possibility of significant artifacts according to their size and their ferromagnetic character, some neurosurgical clips or heart valves can cause problems and require an investigation into the exact model implanted). Topics claustrophobic. Pregnant woman. Neurosurgical ventriculoperitoneal bypass valves. Irremovable metal braces. * CI practice of TMS: the history of epilepsy or seizures during hyperthermia during childhood are related ICs. Ferrométalliques body presence in the brain, cochlear implants, pacemakers, insulin pumps, during pregnancy, about jet lag or not having slept the night before the session of TMS. * Existence of a severe condition in general terms: cardiac, respiratory, hematologic, renal, hepatic, cancerous, * Regular Taking anxiolytics, sedatives, antidepressants, neuroleptics, * Psychiatric disorder characterized, * Alcohol ingestion before the examination, * Persons referred to in Articles L1121-5 to L1121-8 CSP.

Interventions

None listed

Sponsors

Centre National de la Recherche Scientifique, France
CollaboratorOTHER
University Hospital, Grenoble
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* adult subjects (18 to 75 years old) * consent form signed * medical examination done prior to the experiment * affiliated to the French social security

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frameDescription
Electromyographic activity (EMG)One hourParticipants' electromyographic activity will be recorded during an average of one hour.

Secondary

MeasureTime frameDescription
Electroencephalographic activity (EEG)One hourParticipants' electroencephalographic activity will be recorded during an average of one hour.

Other

MeasureTime frameDescription
Oculometry : saccadic eye movementOne hourParticipants' saccadic eye movements will be recorded during an average of one hour.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026